Christopher Missling

Company: Anavex Life Sciences

Job title: President & Chief Executive Officer

Seminars:

Characterizing Rare Disease Biology in Clinical Studies to Observe Drug Effects in Patient Sub-Populations 11:00 am

Understanding the relevance of Whole Exome Sequencing (WES) and mRNA-seq analyses Using unsupervised computerized AI analysis to assess large data Correlating genomic analysis with extensive clinical data outcomes and endpoint scalesRead more

day: Day One